Nuhey News

We talk about the MARKET

Research to Claim USD 6801.2 Mn for Autoimmune Disease Diagnostics Market by 2028

The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.

The global Autoimmune Disease Diagnostics market size is projected to reach US$ 6801.2 million by 2028, from US$ 4906.4 million in 2021, at a CAGR of 4.7% during 2022-2028.

In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Disease Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Disease Diagnostics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Disease Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Disease Diagnostics market.

Request for a free sample or purchase this report at:

Autoimmune Disease Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Analyzers
  • Assay Kits

Segment by Application

  • Hospitals
  • Research Laboratories

By Company

  • Abbott Laboratories
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Euroimmun
  • Inova Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare
  • Diasorin
  • Erba Diagnostics
  • Euro Diagnostica
  • Autoimmune Technologies
  • Avant Diagnostics
  • Exagen Diagnostics
  • Gold Standard Diagnostics
  • Hob Diagnostics
  • Human Diagnostics
  • Immco Diagnostics
  • Immunarray
  • Myriad Genetics
  • Omega Diagnostics
  • Orgentec Diagnostika
  • Phadia
  • Protagen

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479